Stephen McRay
Optometrist · Chickasha, OKNPI 1245204437
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 61 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Alcon accounts for 91.4% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2022 at $214 and has fallen 58.0% since, to $90 in 2023. That places this record below the midpoint for optometrist clinicians in OK, where the typical reported total is $560.
Across 61 payments — averaging $11.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$645
- ABB Con-cise Optical Group LLC$28
- Johnson & Johnson Vision Care, Inc.$19
- Sight Sciences, Inc.$14
What the payments were for
- Food & beverage$706100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 57 | $645 |
| ABB Con-cise Optical Group LLC | 2 | $28 |
| Johnson & Johnson Vision Care, Inc. | 1 | $19 |
| Sight Sciences, Inc. | 1 | $14 |
How this compares
$706 in reported general payments places this provider in the 50th percentile of 714 optometrist providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CombiganBrimonidine Tartrate/Timolol | 20 | $3,429 |
| Prednisolone Acetate | 106 | $2,910 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 19 | $2,329 |
| Latanoprost | 104 | $835 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 19 | $249 |
| Timolol Maleate | 11 | $54 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Chickasha
- Selina McGeeEdmond$1.1M
- Nathan LighthizerTahlequah$1M
- Lindsey BullTulsa$218K
- Jeff MillerTahlequah$67K
- Joseph PhillipsOklahoma City$52K
- Wesley DerosierTulsa$48K
- Charles WhittleTahlequah$28K
- Latricia PackTahlequah$25K
- Scott ForesterOklahoma City$17K
- Cindy ShanTahlequah$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.